ES2182131T3 - Vacuna de pertussis acelular con toxoides de difteria y tetanos. - Google Patents
Vacuna de pertussis acelular con toxoides de difteria y tetanos.Info
- Publication number
- ES2182131T3 ES2182131T3 ES97950137T ES97950137T ES2182131T3 ES 2182131 T3 ES2182131 T3 ES 2182131T3 ES 97950137 T ES97950137 T ES 97950137T ES 97950137 T ES97950137 T ES 97950137T ES 2182131 T3 ES2182131 T3 ES 2182131T3
- Authority
- ES
- Spain
- Prior art keywords
- difteria
- tetans
- accelular
- toxoids
- pertussis vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
- A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
LA INVENCION SUMINISTRA UNA VACUNA PARA LA DIFTERIA, EL TETANOS Y LA TOS FERINA QUE COMPRENDE UNA DOSIS BAJA DE TOXOIDE DE LA DIFTERIA (D), TOXOIDE DEL TETANOS (T), TOXINA DE LA TOS FERINA (PT), HEMAGLUTINA FILAMENTOSA (FHA) Y PERTACTINA (69K). LA VACUNA MANTIENE LA CAPACIDAD DE EVITAR LA TOS FERINA MIENTRAS QUE MUESTRA UNA REACTOGENICIDAD EXCEPCIONALMENTE BAJA. TAMBIEN SE SUMINISTRAN VACUNAS COMBINACIONALES QUE COMPRENDE ANTIGENOS ADICIONALES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9623233.5A GB9623233D0 (en) | 1996-11-07 | 1996-11-07 | Vaccine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2182131T3 true ES2182131T3 (es) | 2003-03-01 |
Family
ID=10802615
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97950137T Expired - Lifetime ES2182131T3 (es) | 1996-11-07 | 1997-11-04 | Vacuna de pertussis acelular con toxoides de difteria y tetanos. |
| ES02075821T Active ES2240647T7 (es) | 1996-11-07 | 1997-11-04 | Vacuna de pertussis acelular con toxoides de difteria y tetanos. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES02075821T Active ES2240647T7 (es) | 1996-11-07 | 1997-11-04 | Vacuna de pertussis acelular con toxoides de difteria y tetanos. |
Country Status (30)
| Country | Link |
|---|---|
| EP (2) | EP1240905B3 (es) |
| JP (1) | JP3980652B2 (es) |
| KR (1) | KR100518044B1 (es) |
| CN (1) | CN1130226C (es) |
| AR (1) | AR011509A1 (es) |
| AT (2) | ATE222773T1 (es) |
| AU (1) | AU710475B2 (es) |
| BR (2) | BRPI9712917B8 (es) |
| CA (1) | CA2271008C (es) |
| CO (1) | CO4910171A1 (es) |
| CY (2) | CY2407B1 (es) |
| CZ (1) | CZ295954B6 (es) |
| DE (3) | DE69715031T2 (es) |
| DK (2) | DK0941117T3 (es) |
| ES (2) | ES2182131T3 (es) |
| GB (1) | GB9623233D0 (es) |
| HK (1) | HK1050473B (es) |
| HU (1) | HU224126B1 (es) |
| IL (1) | IL129530A (es) |
| LU (1) | LU91183I2 (es) |
| NO (2) | NO320186B1 (es) |
| NZ (1) | NZ335384A (es) |
| PL (1) | PL188460B1 (es) |
| PT (2) | PT941117E (es) |
| SA (1) | SA98181128B1 (es) |
| SI (2) | SI0941117T1 (es) |
| TR (1) | TR199900979T2 (es) |
| TW (1) | TW471971B (es) |
| WO (1) | WO1998019702A1 (es) |
| ZA (1) | ZA979984B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1004314A1 (fr) * | 1998-11-26 | 2000-05-31 | Pasteur Merieux MSD | Vaccin T.d. Polio rappel pour une population vaccinée ou sensibilisée |
| KR100374813B1 (ko) * | 2000-04-07 | 2003-03-03 | 녹십자백신 주식회사 | 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법 |
| GB0108364D0 (en) * | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| KR100401423B1 (ko) * | 2001-01-10 | 2003-10-17 | 주식회사 엘지생명과학 | 혼합 백신의 제조 방법 |
| JP5007425B2 (ja) * | 2006-01-30 | 2012-08-22 | 財団法人ヒューマンサイエンス振興財団 | 百日咳ワクチンの安全性評価方法 |
| GB0616306D0 (en) * | 2006-08-16 | 2006-09-27 | Novartis Ag | Vaccines |
| GB0822633D0 (en) * | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
| US9950062B2 (en) | 2009-09-02 | 2018-04-24 | Glaxosmithkline Biologicals Sa | Compounds and compositions as TLR activity modulators |
| JP2013538217A (ja) | 2010-09-01 | 2013-10-10 | ノバルティス アーゲー | 不溶性金属塩への免疫増強物質の吸着 |
| CN103533954B (zh) | 2011-03-02 | 2015-09-09 | 诺华股份有限公司 | 含较低剂量的抗原和/或佐剂的联合疫苗 |
| CN102363041A (zh) * | 2011-11-17 | 2012-02-29 | 成都欧林生物科技股份有限公司 | 不含防腐剂疫苗的制作工艺 |
| CA2866406A1 (en) | 2012-03-08 | 2013-09-12 | Novartis Ag | Adjuvanted formulations of booster vaccines |
| CN102793915B (zh) * | 2012-07-25 | 2013-10-23 | 天津康希诺生物技术有限公司 | 一种无细胞百日咳疫苗的生产方法 |
| US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| SG11201500573RA (en) | 2012-08-06 | 2015-02-27 | Glaxosmithkline Biolog Sa | Method for eliciting in infants an immune response against rsv and b. pertussis |
| CN103100081A (zh) * | 2012-12-26 | 2013-05-15 | 天津康希诺生物技术有限公司 | 一种多价联合疫苗 |
| BR112015021523A8 (pt) | 2013-03-08 | 2021-06-29 | Crucell Holland Bv | composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis |
| SG11201600709TA (en) | 2013-08-05 | 2016-02-26 | Glaxosmithkline Biolog Sa | Combination immunogenic compositions |
| CN114748616A (zh) * | 2022-05-23 | 2022-07-15 | 中国医学科学院医学生物学研究所 | 一种成人青少年用无细胞百白破联合疫苗及其制备方法 |
| CN117417419B (zh) * | 2023-01-10 | 2024-04-19 | 康希诺生物股份公司 | 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗 |
| CN119524117B (zh) * | 2025-01-23 | 2025-09-23 | 康希诺生物股份公司 | 免疫原性组合物、百白破联合疫苗及其制备方法和应用 |
| CN119548620B (zh) * | 2025-01-23 | 2025-09-12 | 康希诺生物股份公司 | 一种用于预防白喉、百日咳和破伤风的免疫原性组合物、疫苗及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI861417A0 (fi) | 1985-04-15 | 1986-04-01 | Endotronics Inc | Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav. |
| US4895800A (en) | 1985-11-26 | 1990-01-23 | Phillips Petroleum Company | Yeast production of hepatitis B surface antigen |
| ZA88488B (en) | 1987-01-30 | 1988-10-26 | Smith Kline Rit | Hepatitis b virus surface antigens and hybrid antigens containing them |
| EP0304578B1 (en) | 1987-06-22 | 2001-10-24 | Medeva Holdings Bv | Peptide comprising hepatitis B surface antigen |
| DE3789866T2 (de) | 1987-07-17 | 1994-09-22 | Rhein Biotech Gesellschaft Fuer Neue Biotechnologische Prozesse Und Produkte Mbh, 40595 Duesseldorf | DNA-Moleküle, die für FMDH-Kontrollabschnitte und Strukturgene für ein Protein mit FMDH-Aktivität kodieren, sowie deren Anwendung. |
| DK0414374T3 (da) | 1989-07-25 | 1998-03-09 | Smithkline Beecham Biolog | Hidtil ukendte antigener og fremgangsmåder til fremstilling deraf |
| GB9007024D0 (en) | 1990-03-29 | 1990-05-30 | Imperial College | Novel vaccine |
| JP3626996B2 (ja) * | 1992-05-23 | 2005-03-09 | グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム | B型肝炎表面抗原および他の抗原からなる複合ワクチン |
-
1996
- 1996-11-07 GB GBGB9623233.5A patent/GB9623233D0/en active Pending
-
1997
- 1997-11-04 SI SI9730394T patent/SI0941117T1/xx unknown
- 1997-11-04 PT PT97950137T patent/PT941117E/pt unknown
- 1997-11-04 TR TR1999/00979T patent/TR199900979T2/xx unknown
- 1997-11-04 NZ NZ335384A patent/NZ335384A/xx not_active IP Right Cessation
- 1997-11-04 AT AT97950137T patent/ATE222773T1/de active
- 1997-11-04 PT PT02075821T patent/PT1240905E/pt unknown
- 1997-11-04 WO PCT/EP1997/006180 patent/WO1998019702A1/en not_active Ceased
- 1997-11-04 BR BRPI9712917A patent/BRPI9712917B8/pt unknown
- 1997-11-04 AU AU53196/98A patent/AU710475B2/en not_active Expired
- 1997-11-04 ES ES97950137T patent/ES2182131T3/es not_active Expired - Lifetime
- 1997-11-04 HU HU9904287A patent/HU224126B1/hu active IP Right Grant
- 1997-11-04 IL IL12953097A patent/IL129530A/xx not_active IP Right Cessation
- 1997-11-04 EP EP02075821A patent/EP1240905B3/en not_active Expired - Lifetime
- 1997-11-04 JP JP52107098A patent/JP3980652B2/ja not_active Expired - Lifetime
- 1997-11-04 DE DE69715031T patent/DE69715031T2/de not_active Expired - Lifetime
- 1997-11-04 SI SI9730706T patent/SI1240905T1/xx unknown
- 1997-11-04 DK DK97950137T patent/DK0941117T3/da active
- 1997-11-04 DK DK02075821T patent/DK1240905T5/da active
- 1997-11-04 BR BR9712917-8A patent/BR9712917A/pt not_active IP Right Cessation
- 1997-11-04 CN CN97199491A patent/CN1130226C/zh not_active Expired - Lifetime
- 1997-11-04 CZ CZ19991640A patent/CZ295954B6/cs not_active IP Right Cessation
- 1997-11-04 KR KR10-1999-7004016A patent/KR100518044B1/ko not_active Expired - Lifetime
- 1997-11-04 ES ES02075821T patent/ES2240647T7/es active Active
- 1997-11-04 AT AT02075821T patent/ATE295178T1/de active
- 1997-11-04 CA CA002271008A patent/CA2271008C/en not_active Expired - Lifetime
- 1997-11-04 EP EP97950137A patent/EP0941117B1/en not_active Expired - Lifetime
- 1997-11-04 DE DE69733285T patent/DE69733285T3/de not_active Expired - Lifetime
- 1997-11-06 AR ARP970105177A patent/AR011509A1/es active IP Right Grant
- 1997-11-06 ZA ZA979984A patent/ZA979984B/xx unknown
- 1997-11-07 CO CO97065487A patent/CO4910171A1/es unknown
- 1997-12-24 TW TW086119712A patent/TW471971B/zh not_active IP Right Cessation
-
1998
- 1998-04-25 SA SA98181128A patent/SA98181128B1/ar unknown
-
1999
- 1999-05-04 NO NO19992156A patent/NO320186B1/no not_active IP Right Cessation
- 1999-05-05 PL PL97333127A patent/PL188460B1/pl unknown
-
2000
- 2000-03-10 HK HK03101055.7A patent/HK1050473B/en not_active IP Right Cessation
-
2004
- 2004-02-26 CY CY0400014A patent/CY2407B1/xx unknown
-
2005
- 2005-06-16 DE DE200512000046 patent/DE122005000046I1/de active Pending
- 2005-07-20 LU LU91183C patent/LU91183I2/fr unknown
-
2006
- 2006-04-25 NO NO2006005C patent/NO2006005I2/no unknown
- 2006-11-09 CY CY0600031A patent/CY2568B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR011509A1 (es) | Composicion de vacuna que comprende antigenos de difteria, tetano y tos ferina(pertusis) acelular y su uso para la manufactura de un medicamento util como reforzador de vacuna. | |
| IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
| AR025750A1 (es) | Vacunas | |
| AU5741001A (en) | Epitope synchronization in antigen presenting cells | |
| ES2150493T3 (es) | Adyuvantes para vacunas contra el virus sincitico respiratorio. | |
| AR020836A1 (es) | Vacunas | |
| BR9106748A (pt) | Vacina de hyopneumomiae micoplasma inativado e metodo de seu uso | |
| AR044985A1 (es) | Metodo y parche de inmunizacion por disposicion de microproyeccion | |
| HUP9901901A2 (hu) | Hepatitis C elleni vakcinák | |
| NO20015073D0 (no) | Vaksiner | |
| FR2781159B1 (fr) | Vaccin circovirus et parvovirus porcin | |
| FI913820A0 (fi) | Traodlikt hemagglutinin fraon bordetella pertussis som baerarmolekyl foer konjugatvaccin. | |
| LU91594I2 (fr) | Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3 (Infanrix - IPV) | |
| MX9709870A (es) | Uso de esporocistos u occistos para preparar una vacuna contra coccidiosis. | |
| ATE270707T1 (de) | Entepneumovirus und entsprechendes impfstoff | |
| CY1112658T1 (el) | Εμβολια τα οποια περιεχουν αντιγονο μαgε συνδεομενο με θραυσμα πρωτεϊνης d | |
| CY1110327T1 (el) | DTPa ΕΜΒΟΛΙΑ ΒΛΕΝΝΟΓΟΝΟΥ | |
| ES2079358T3 (es) | Vacuna reasociante de rotavirus. | |
| ES2158857T3 (es) | Vacunas a base de estreptoquinasa. | |
| UA42741C2 (uk) | Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти) | |
| GB0031079D0 (en) | Vaccine | |
| ES2104490B1 (es) | Conjunto de vacunacion contra la enterotoxemia del conejo y vacuna acondicionada para ser utilizada en este conjunto. | |
| FR2796282B1 (fr) | Vaccin inactive contre la calicivirose feline | |
| ECSP961731A (es) | Vacunas | |
| CY1117601T1 (el) | Ανασυνδυασμενα εμβολια κατα κωπηποδων καλιγιδων (θαλασσιων ψειρων) και αλληλουχιες αντιγονων αυτων |